Product image of Metformini Hydrochloridum Lnventla Healthcare B.V. (Metformin Hydrochloride) supplied by GNH India

Metformini Hydrochloridum Lnventla Healthcare B.V.

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformini Hydrochloridum Lnventla Healthcare B.V. (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformini Hydrochloridum Lnventla Healthcare B.V., is a biguanide presented as an oral tablet for oral use. It helps lower blood glucose in adults with type 2 diabetes mellitus.

GNH India supplies Metformini Hydrochloridum Lnventla Healthcare B.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Inventia Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformin Hydrochloride is used to manage hyperglycaemia in the type 2 diabetes mellitus pathway.

  • Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose levels.
  • Prediabetes (off‑label): may delay progression to overt diabetes when used under medical supervision.
  • Polycystic ovary syndrome (off‑label): can improve insulin resistance and menstrual regularity.

How It Works

  • Metformin Hydrochloride primarily inhibits hepatic gluconeogenesis, reducing glucose output from the liver. It also enhances peripheral insulin sensitivity by increasing glucose uptake in muscle and adipose tissue and modestly decreases intestinal absorption of glucose, collectively contributing to lower plasma glucose concentrations.

Side Effects

Metformin Hydrochloride is associated with a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhoea: frequent loose stools, especially at treatment initiation.
  • Abdominal discomfort: cramping or bloating.
  • Metallic taste: transient alteration in taste perception.
  • Weight loss: modest reduction in body weight.
  • Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: rare but potentially fatal metabolic acidosis.
  • Severe skin reactions: such as Stevens‑Johnson syndrome.
  • Hepatotoxicity: liver enzyme elevations.
  • Hypoglycaemia: when combined with insulin or secretagogues.
  • Pancreatitis: inflammation of the pancreas.
  • Anemia: due to reduced red blood cell production.

Precautions & Warnings

Metformin Hydrochloride requires careful monitoring and patient education.

  • Renal function: assess creatinine clearance before initiation and periodically thereafter.
  • Hepatic impairment: avoid in patients with significant liver disease.
  • Contraindication: do not use in patients with severe renal insufficiency (eGFR <30 mL/min/1.73 m²).
  • Alcohol consumption: limit intake to reduce risk of lactic acidosis.
  • Elderly patients: start at lower doses and titrate slowly.
  • Store at room temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metformin Hydrochloride can interact with several medicines, requiring vigilance.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
  • Cimetidine: can raise metformin plasma concentrations.
  • Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycaemia symptoms.
  • Diuretics: can affect renal clearance of metformin.
  • ACE inhibitors/ARBs: monitor renal function and potassium levels.
  • Oral contraceptives: may slightly increase metformin levels.
  • Anticoagulants (e.g., warfarin): monitor INR as metformin may alter INR stability.

Frequently Asked Questions

Metformini Hydrochloridum contains metformin hydrochloride, which is prescribed to lower elevated blood glucose levels in adults with type 2 diabetes mellitus. It helps improve overall glycaemic control when used as part of a comprehensive diabetes management plan.

Metformin works by inhibiting hepatic glucose production, increasing insulin‑mediated glucose uptake in peripheral tissues, and reducing intestinal glucose absorption. These actions collectively lower fasting and post‑prandial blood glucose concentrations.

The exact dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Metformin may be used during pregnancy only if clearly needed and prescribed by a qualified obstetrician, as safety data are limited. It is excreted in breast milk, so a risk‑benefit assessment should be performed before breastfeeding while on metformin.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is a first‑line biguanide that improves insulin sensitivity without causing weight gain, unlike some sulfonylureas or insulin. It has a well‑established safety profile and is generally less expensive than newer agents such as GLP‑1 receptor agonists or SGLT2 inhibitors.

Store the product at room temperature, below 25 °C, in the original packaging. Keep it away from moisture, direct sunlight and heat sources to maintain product stability.

Metformini Hydrochloridum is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute medical illnesses. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformini Hydrochloridum should be avoided in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or in patients undergoing radiographic studies using iodinated contrast agents without appropriate renal monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.